What reinfections mean for COVID-19

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020

Singanayagam, A., Patel, M., Charlett, A., Lopez Bernal, J., Saliba, V., Ellis, J., Ladhani, S., Zambon, M., & Gopal, R. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.32.2001483 · Cited by 846 · see citing works

Seasonal coronavirus protective immunity is short-lasting

Edridge, A. W. D., Kaczorowska, J., Hoste, A. C. R., Bakker, M., Klein, M., Loens, K., Jebbink, M. F., Matser, A., Kinsella, C. M., Rueda, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1083-1 · Cited by 767 · see citing works

Genomic evidence for reinfection with SARS-CoV-2: a case study

Tillett, R. L., Sevinsky, J. R., Hartley, P. D., Kerwin, H., Crawford, N. F., Gorzalski, A. J., Laverdure, C., Verma, S. C., Rossetto, C. C., Jackson, D. K., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30764-7 · Cited by 755 · see citing works

Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing

To, K. K.-W., Hung, I. F.-N., Ip, J. D., Chu, A. W.-H., Chan, W.-M., Tam, A. R., Fong, C. H.-Y., Yuan, S., Tsoi, H.-W., Ng, A. C.-K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1275 · Cited by 746 · see citing works

Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain

Elslande, J. V., Vermeersch, P., Vandervoort, K., Wawina-Bokalanga, T., Vanmechelen, B., Wollants, E., Laenen, L., André, E., Ranst, M. A. V., Lagrou, K., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1330 · Cited by 238 · see citing works

A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants

Dearlove, B. L., Lewitus, É., Bai, H., Li, Y., Reeves, D. B., Joyce, M. G., Scott, P. T., Amare, M. F., Vasan, S., Michael, N. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008281117 · Cited by 199 · see citing works

Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain.

Elslande, J. V., Vermeersch, P., Vandervoort, K., Wawina-Bokalanga, T., Vanmechelen, B., Wollants, E., Laenen, L., André, E., Ranst, M. A. V., Lagrou, K., et al. (2020) · Clinical Infectious Diseases · Cited by 133 · see citing works

COVID-19 Re-Infection by a Phylogenetically Distinct SARS-CoV-2 Variant, First Confirmed Event in South America.Preprint

Prado-Vivar, B., Becerra-Wong, M., Guadalupe, J. J., Márquez, S., Gutiérrez, B., Rojas‐Silva, P., Grunauer, M., Trueba, G. A., Barragán, V., & Cárdenas, P. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3686174 · Cited by 91 · see citing works

Immune determinants of COVID-19 disease presentation and severity

Brodin, P. (2021) · Nature Medicine · doi:10.1038/s41591-020-01202-8 · Cited by 654 · see citing works

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Hall, V. J., Foulkes, S., Charlett, A., Atti, A., Monk, E. J. M., Simmons, R., Wellington, E., Cole, M. J., Saei, A., Oguti, B., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00675-9 · Cited by 638 · see citing works

Looking beyond COVID-19 vaccine phase 3 trials

Kim, J. H., Marks, F., & Clemens, J. D. (2021) · Nature Medicine · doi:10.1038/s41591-021-01230-y · Cited by 586 · see citing works

Coronavirus vaccine development: from SARS and MERS to COVID-19

Li, Y.-D., Chi, W.-Y., Su, J.-H., Ferrall, L., Hung, C., & Wu, T. ‐. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00695-2 · Cited by 461 · see citing works

The first 12 months of COVID-19: a timeline of immunological insights

Carvalho, T., Krammer, F., & Iwasaki, A. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00522-1 · Cited by 448 · see citing works

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

Zuo, J., Dowell, A. C., Pearce, H., Verma, K., Long, H. M., Begum, J., Aiano, F., Amin-Chowdhury, Z., Hoschler, K., Brooks, T., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00902-8 · Cited by 392 · see citing works

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review

Piechotta, V., Chai, K. L., Valk, S. J., Doree, C. J., Monsef, I., Wood, E. M., Lamikanra, A., Kimber, C., McQuilten, Z., So‐Osman, C., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub2 · Cited by 365 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study

Gazit, S., Shlezinger, R., Perez, G., Lotan, R., Peretz, A., Ben-Tov, A., Herzel, E., Alapi, H., Cohen, D., Muhsen, K., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac262 · Cited by 283 · see citing works

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection

Harvey, R. A., Rassen, J. A., Kabelac, C. A., Turenne, W. M., Leonard, S., Klesh, R., Meyer, W. A., Kaufman, H. W., Anderson, S., Cohen, O. J., et al. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.0366 · Cited by 262 · see citing works

Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review

Byambasuren, O., Dobler, C. C., Bell, K., Rojas, D. P., Clark, J. M., McLaws, M., & Glasziou, P. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248946 · Cited by 250 · see citing works

Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity

Yahav, D., Yelin, D., Eckerle, I., Eberhardt, C. S., Wang, J., Cao, B., & Kaiser, L. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.11.028 · Cited by 229 · see citing works

COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses

Bonifacius, A., Tischer-Zimmermann, S., Dragon, A., Gussarow, D., Vogel, A. J., Krettek, U., Gödecke, N., Yilmaz, M., Kraft, A. R. M., Hoeper, M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.008 · Cited by 186 · see citing works

Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults

Ward, H., Cooke, G., Atchison, C. J., Whitaker, M. D., Elliott, J., Moshe, M., Brown, J. C., Flower, B., Daunt, A., Ainslie, K. E. C., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100098 · Cited by 193 · see citing works

COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection

Escandón-Vargas, K., Rasmussen, A. L., Bogoch, I. I., Murray, E. J., Escandón, K., Popescu, S. V., & Kindrachuk, J. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06357-4 · Cited by 194 · see citing works

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review

Piechotta, V., Iannizzi, C., Chai, K. L., Valk, S. J., Kimber, C., Dorando, E., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub4 · Cited by 186 · see citing works

COVID‐19 vaccinations: The unknowns, challenges, and hopes

Mohamed, K., Rzymski, P., Islam, M. S., Makuku, R., Mushtaq, A., Khan, A., Ivanovska, M., Makka, S. A., Hashem, F., Marquez, L. P., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27487 · Cited by 145 · see citing works

COVID-19 reinfections among naturally infected and vaccinated individuals

Rahman, S., Rahman, M. M., Miah, M., Begum, M. N., Sarmin, M., Mahfuz, M., Hossain, M. E., Rahman, M. Z., Chisti, M. J., Ahmed, T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05325-5 · Cited by 108 · see citing works

Sexual dimorphism in COVID-19: potential clinical and public health implications

Bechmann, N., Barthel, A., Schedl, A., Herzig, S., Varga, Z., Gebhard, C., Mayr, M., Hantel, C., Beuschlein, F., Wolfrum, C., et al. (2022) · Publikationen an der Universität Bielefeld (Universität Bielefeld) · Cited by 110 · see citing works

Sexual dimorphism in COVID-19: potential clinical and public health implications

Bechmann, N., Barthel, A., Schedl, A., Herzig, S., Varga, Z., Gebhard, C., Mayr, M., Hantel, C., Beuschlein, F., Wolfrum, C., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00346-6 · Cited by 116 · see citing works

Fast and noninvasive electronic nose for sniffing out COVID-19 based on exhaled breath-print recognition

Nurputra, D. K., Kusumaatmaja, A., Hakim, M. S., Hidayat, S. N., Julian, T., Sumanto, B., Mahendradhata, Y., Saktiawati, A. M. I., Wasisto, H. S., & Trıyana, K. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00661-2 · Cited by 108 · see citing works

Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection

Hanrath, A. T., Payne, B. A. I., & Duncan, C. J. A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.12.023 · Cited by 103 · see citing works

Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020Preprint

Hall, V. J., Foulkes, S., Charlett, A., Atti, A., Monk, E., Simmons, R., Wellington, E., Cole, M., Saei, A., Oguti, B., et al. (2021) · medRxiv · doi:10.1101/2021.01.13.21249642 · Cited by 94 · see citing works

The 2020 race towards SARS-CoV-2 specific vaccines

Karpiński, T. M. M., Ożarowski, M., Seremak‐Mrozikiewicz, A., Wolski, H., & Włodkowic, D. (2020) · Theranostics · doi:10.7150/thno.53691 · Cited by 92 · see citing works

A case of SARS-CoV-2 reinfection in Ecuador

Prado-Vivar, B., Becerra-Wong, M., Guadalupe, J. J., Márquez, S., Gutiérrez, B., Rojas‐Silva, P., Grunauer, M., Trueba, G. A., Barragán, V., & Cárdenas, P. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30910-5 · Cited by 86 · see citing works

Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients

DeKosky, S. T., Kochanek, P. M., Valadka, A. B., Clark, R. S. B., Chou, S., Au, A. K., Horvat, C. M., Jha, R. M., Mannix, R., Wisniewski, S. R., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7332 · Cited by 83 · see citing works

Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease

Ricke‐Hoch, M., Stelling, E., Laßwitz, L., Gunesch, A. P., Kasten, M., Belinchón, F. J. Z., Brogden, G., Gerold, G., Pietschmann, T., Montiel, V., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255335 · Cited by 81 · see citing works

Noncompliance With Safety Guidelines as a Free-Riding Strategy: An Evolutionary Game-Theoretic Approach to Cooperation During the COVID-19 Pandemic

Yong, J. C., & Choy, B. K. C. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.646892 · Cited by 75 · see citing works

Preparing for the Coronavirus Disease (COVID-19) Vaccination: Evidence, Plans, and Implications

Jung, J. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e59 · Cited by 74 · see citing works

SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity

Nielsen, S., Vibholm, L. K., Monrad, I., Olesen, R., Frattari, G. S., Pahus, M. H., Højen, J. F., Gunst, J., Erikstrup, C., Holleufer, A., et al. (2020) · bioRxiv · doi:10.1016/j.ebiom.2021.103410 · Cited by 65 · see citing works

Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection

Clarke, C., Prendecki, M. F., Dhutia, A., Gan, J. J. L., Edwards, C., Prout, V., Lightstone, L., Parker, E. L., Marchesin, F., Griffith, M. E., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.03.009 · Cited by 68 · see citing works

A case of COVID-19 reinfection in the UK

West, J., Everden, S., & Nikitas, N. (2020) · Clinical Medicine · doi:10.7861/clinmed.2020-0912 · Cited by 66 · see citing works

Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study

Krutikov, M., Palmer, T., Tut, G., Fuller, C., Shrotri, M., Williams, H., Davies, D., Irwin-Singer, A., Robson, J., Hayward, A. C., et al. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00093-3 · Cited by 63 · see citing works

Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study

Leidi, A., Koegler, F., Dumont, R., Dubos, R., Zaballa, M.-E., Piumatti, G., Coen, M., Berner, A., Farhoumand, P. D., Vetter, P., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab495 · Cited by 62 · see citing works

Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson’s Disease

Awogbindin, I. O., Ben‐Azu, B., Olusola, B. A., Akinluyi, E. T., Adeniyi, P. A., Paolo, T. D., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.670298 · Cited by 60 · see citing works

A review of mathematical model-based scenario analysis and interventions for COVID-19

Padmanabhan, R., Abed, H. S., Meskin, N., Khattab, T. M., Shraim, M., & Al-Hitmi, M. A. E. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106301 · Cited by 62 · see citing works

Multiple COVID-19 Waves and Vaccination Effectiveness in the United States

Lin, L., Zhao, Y., Chen, B., & He, D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042282 · Cited by 61 · see citing works

Reinfection rates among patients previously infected by SARS-CoV-2: systematic review and meta-analysis

Mao, Y., Wang, W., Ma, J., Wu, S., & Sun, F. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001892 · Cited by 60 · see citing works

SARS-CoV-2: vaccines in the pandemic era

Li, D., & Li, Q. (2021) · Military Medical Research · doi:10.1186/s40779-020-00296-y · Cited by 59 · see citing works

Do Antibody Positive Healthcare Workers Have Lower SARS-CoV-2 Infection Rates than Antibody Negative Healthcare Workers? Large Multi-Centre Prospective Cohort Study (The SIREN Study), England: June to November 2020Preprint

Hall, V. J., Foulkes, S., Charlett, A., Atti, A., Monk, E. J. M., Simmons, R., Wellington, E., Cole, M. J., Saei, A., Oguti, B., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3768524 · Cited by 59 · see citing works

The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine

Gazit, S., Shlezinger, R., Perez, G., Lotan, R., Peretz, A., Ben‐Tov, A., Herzel, E., Alapi, H., Cohen, D., Muhsen, K., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m21-4130 · Cited by 56 · see citing works

Dynamics of a Dual SARS-CoV-2 Lineage Co-Infection on a Prolonged Viral Shedding COVID-19 Case: Insights into Clinical Severity and Disease Duration

Pedro, N., Silva, C., Magalhães, A. C., Cavadas, B., Rocha, A. M., Moreira, A. C., Gomes, M. S., Silva, D., Sobrinho‐Simões, J., Ramos, A., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9020300 · Cited by 53 · see citing works

Incorporating Social Determinants of Health into Modelling of COVID-19 and other Infectious Diseases: A Baseline Socio-economic Compartmental Model

Galanis, G., & Hanieh, A. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.113794 · Cited by 54 · see citing works

Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality

Haghpanah, F., Lin, G., Levin, S. A., & Klein, E. Y. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100863 · Cited by 54 · see citing works

The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis

Chivese, T., Matizanadzo, J. T., Musa, O. A. H., Hindy, G., Furuya‐Kanamori, L., Islam, N., Al-Shebly, R., Shalaby, R., Habibullah, M., Al-Marwani, T. A., et al. (2022) · Pathogens and Global Health · doi:10.1080/20477724.2022.2029301 · Cited by 53 · see citing works

Ct values and infectivity of SARS-CoV-2 on surfaces

Kampf, G., Lemmen, S., & Suchomel, M. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30883-5 · Cited by 52 · see citing works

Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: A preliminary report

Pal, R., Sachdeva, N. K., Mukherjee, S., Suri, V., Zohmangaihi, D., Ram, S., Puri, G. D., Bhalla, A., Soni, S. L., Pandey, N., et al. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.12.035 · Cited by 52 · see citing works

Convalescent plasma for people with COVID-19: a living systematic review

Iannizzi, C., Chai, K. L., Piechotta, V., Valk, S. J., Kimber, C., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., McQuilten, Z., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub5 · Cited by 44 · see citing works

Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases

Kronbichler, A., Anders, H., Juarez, G. M. F., Floege, J., Goumenos, D. S., Segelmark, M., Tesař, V., Türkmen, K., van Kooten, C., & Bruchfeld, A. N. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab064 · Cited by 43 · see citing works

Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection

Marchi, S., Viviani, S., Remarque, E. J., Ruello, A., Bombardieri, E., Bollati, V., Milani, G. P., Manenti, A., Lapini, G., Rebuffat, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253977 · Cited by 42 · see citing works

Immunology of COVID ‐19

Brüssow, H. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.15302 · Cited by 54 · see citing works

Vaccination passports: Challenges for a future of air transportation

Sun, X., Wandelt, S., & Zhang, A. (2021) · Transport Policy · doi:10.1016/j.tranpol.2021.06.018 · Cited by 41 · see citing works

The mystery of COVID-19 reinfections: A global systematic review and meta-analysis

Dhillon, R. A., Qamar, M. A., Gilani, J. A., Irfan, O., Waqar, U., Sajid, M. I., & Mahmood, S. F. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.103130 · Cited by 40 · see citing works

Airborne infection risks of SARS-CoV-2 in U.S. schools and impacts of different intervention strategies

Xu, Y., Cai, J., Shuai, L. I., He, Q., & Zhu, S. (2021) · Sustainable Cities and Society · doi:10.1016/j.scs.2021.103188 · Cited by 41 · see citing works

Convalescent plasma for people with COVID-19: a living systematic review

Iannizzi, C., Chai, K. L., Piechotta, V., Valk, S. J., Kimber, C., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., McQuilten, Z., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub6 · Cited by 41 · see citing works

The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcome

Anderson, R. M., Vegvari, C., Hollingsworth, T. D., Pi, L., Maddren, R., Ng, C. W., & Baggaley, R. F. (2021) · Interface Focus · doi:10.1098/rsfs.2021.0008 · Cited by 37 · see citing works

Modeling the COVID-19 pandemic: a primer and overview of mathematical epidemiology

Saldaña, F., & Velasco‐Hernández, J. X. (2021) · SeMA Journal · doi:10.1007/s40324-021-00260-3 · Cited by 37 · see citing works

Dynamics of SARS-CoV-2 with waning immunity in the UK population

Crellen, T., Pi, L., Davis, E. L., Pollington, T. M., Lucas, T. C. D., Ayabina, D. V., Borlase, A., Toor, J., Prem, K., Medley, G. F., et al. (2021) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2020.0274 · Cited by 30 · see citing works

Repeated SARS-CoV-2 Positivity: Analysis of 123 Cases

Váncsa, S., Dembrovszky, F., Farkas, N., Szakó, L., Teutsch, B., Bunduc, Ș., Nagy, R., Párniczky, A., Erőss, B. M., Péterfi, Z., et al. (2021) · Viruses · doi:10.3390/v13030512 · Cited by 32 · see citing works

Prolonged viral shedding and antibody persistence in patients with COVID-19

Fotouhi, F., Salehi-Vaziri, ‪., Farahmand, B., Mostafavi, E., Pouriayevali, M. H., Jalali, T., Mazaheri, V., Larijani, M. S., Tavakoli, M., Mohammadnejad, A. E., et al. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104810 · Cited by 31 · see citing works

Acceptance of a vaccine against COVID-19 – a systematic review of surveys conducted worldwide

Snehota, M., Vlčková, J., Čížková, K., Vachutka, J., Kolarova, H., Klaskova, E., & Kollárová, H. (2021) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2021_086 · Cited by 30 · see citing works

Evaluation of the United States COVID-19 vaccine allocation strategy

Islam, M. R., Oraby, T. F., McCombs, A., Chowdhury, M. M., Al-Mamun, M. A., Tyshenko, M. G., & Kadelka, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259700 · Cited by 31 · see citing works

Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran

Salehi-Vaziri, ‪., Jalali, T., Farahmand, B., Fotouhi, F., Banifazl, M., Pouriayevali, M. H., Larijani, M. S., Afzali, N., & Ramezani, A. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04221-6 · Cited by 30 · see citing works

Regression Models for Understanding COVID-19 Epidemic Dynamics With Incomplete Data

Quick, C., Dey, R., & Lin, X. (2021) · Journal of the American Statistical Association · doi:10.1080/01621459.2021.2001339 · Cited by 28 · see citing works

COVID-19 Research: Lessons from Non-Human Primate Models

Albrecht, L., Bishop, E., Jay, B., Lafoux, B., Minoves, M., & Passaes, C. (2021) · Vaccines · doi:10.3390/vaccines9080886 · Cited by 28 · see citing works

COVID-19 diverse outcomes: Aggravated reinfection, type I interferons and antibodies

Silva, R. C. M. C., Bandeira‐Melo, C., Neto, H. A. P., Vale, A. M., & Travassos, L. H. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110943 · Cited by 27 · see citing works

COVID-19 Testing and the Impact of the Pandemic on the Miami Adult Studies on HIV Cohort

Tamargo, J. A., Martin, H. R., Diaz‐Martinez, J., Trepka, M. J., Delgado‐Enciso, I., Johnson, A., Mandler, R. N., Siminski, S. M., Gorbach, P. M., & Baum, M. K. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002680 · Cited by 27 · see citing works

Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative

Shalash, A. O., Hussein, W. M., Skwarczyński, M., & Tóth, I. (2021) · Advanced Science · doi:10.1002/advs.202100985 · Cited by 25 · see citing works

Re‐infection in COVID‐19: Do we exaggerate our worries?

Arslan, Y., Akgül, F., Sevim, B., Varol, Z. S., & Tekin, S. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13767 · Cited by 25 · see citing works

Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation

Gazit, S., Saciuk, Y., Perez, G., Peretz, A., Ben‐Tov, A., Stuart, E. A., & Patalon, T. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00103-9 · Cited by 24 · see citing works

A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary reportPreprint

Perez, G., Banon, T., Gazit, S., Moshe, S. B., Wortsman, J., Grupel, D., Peretz, A., Ben‐Tov, A., Chodick, G., Mizrahi-Reuveni, M., et al. (2021) · medRxiv · doi:10.1101/2021.03.06.21253051 · Cited by 25 · see citing works

Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak — Kentucky, July–November 2020

Cavanaugh, A. M., Thoroughman, D. A., Miranda, H., & Spicer, K. B. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7008a3 · Cited by 24 · see citing works

The Impact of Increasing Disease Prevalence, False Omissions, and Diagnostic Uncertainty on Coronavirus Disease 2019 (COVID-19) Test Performance

Kost, G. J. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0716-sa · Cited by 23 · see citing works

Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay

Higgins, R. L., Rawlings, S., Case, J., Lee, F., Chan, C., Barrick, B. L., Burger, Z., Yeo, K., & Marrinucci, D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247797 · Cited by 25 · see citing works

Public views about COVID-19 ‘Immunity Passports’

Hall, M. A., & Studdert, D. M. (2021) · Journal of Law and the Biosciences · doi:10.1093/jlb/lsab016 · Cited by 22 · see citing works

The REinfection in COVID‐19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers

Racine, É., Boivin, G., Longtin, Y., McCormack, D., Decaluwe, H., Savard, P., Cheng, M. P., Hamelin, M., Carbonneau, J., Tadount, F., et al. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12997 · Cited by 18 · see citing works

Persistent viral RNA shedding in COVID-19: Caution, not fear

Plebani, M. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103234 · Cited by 22 · see citing works

Protective Effect of Melatonin Administration against SARS-CoV-2 Infection: A Systematic Review

Molina‐Carballo, A., Palacios-López, R., Jerez-Calero, A. E., Augustin-Morales, M. D. C., Agil, A., Muñoz‐Hoyos, A., & Muñoz-Gallego, A. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb44010003 · Cited by 21 · see citing works

From Isolation to Containment: Perceived Fear of Infectivity and Protective Behavioral Changes during the COVID-19 Vaccination Campaign

Kaim, A., Siman‐Tov, M., Jaffe, E., & Adini, B. B. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18126503 · Cited by 19 · see citing works

COVID-19 reinfection in Liberia: Implication for improving disease surveillance

Akpan, G. E., Bawo, L., Amo-Addae, M. P., Kennedy, J. B. M., Wesseh, C. S., Whesseh, F., Adewuyi, P. A., Blebo, L. S., Babalola, J., Wilson, H. W., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265768 · Cited by 19 · see citing works

Analysis of multi-strain infection of vaccinated and recovered population through epidemic model: Application to COVID-19

Otunuga, O. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271446 · Cited by 18 · see citing works

Drug-Based Therapeutic Strategies for COVID-19-Infected Patients and Their Challenges

Zarkesh, K., Entezar-Almahdi, E., Ghasemiyeh, P., Akbarian, M., Bahmani, M., Roudaki, S., Fazlinejad, R., Mohammadi‐Samani, S., Firouzabadi, N., Hosseini, M., et al. (2021) · Future Microbiology · doi:10.2217/fmb-2021-0116 · Cited by 18 · see citing works

An immune correlate of SARS-CoV-2 infection and severity of reinfectionsPreprint

Maier, H. E., Balmaseda, Á., Ojeda, S., Cerpas, C., Sánchez, N., Plazaola, M., van Bakel, H., Kubale, J., López, R., SABORÍO, S. I., et al. (2021) · medRxiv · doi:10.1101/2021.11.23.21266767 · Cited by 16 · see citing works

Virtual screening of functional foods and dissecting their roles in modulating gene functions to support post COVID‐19 complications

Afroz, S., Fairuz, S., Joty, J. A., Uddin, M. N., & Rahman, M. A. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13961 · Cited by 16 · see citing works

Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models

Yang, H., Cao, J. A., Lin, X., Yue, J., Zieneldien, T., Kim, J., Wang, L., Fang, J., Huang, R., Bai, Y., et al. (2022) · Viruses · doi:10.3390/v14030449 · Cited by 17 · see citing works

Reinfection of SARS-CoV-2 – analysis of 23 cases from the literature

Roberts, A. T., Piani, F., Longo, B., Andreini, R., & Meini, S. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1905174 · Cited by 17 · see citing works

SARS-CoV-2 Reinfection among Healthcare Workers in Mexico: Case Report and Literature Review

Garduño-Orbe, B., Sánchez-Rebolledo, J. M., Cortés-Rafael, M., García-Jiménez, Y., Perez-Ortiz, M., Mendiola-Pastrana, I. R., López‐Ortiz, E., & López-Ortiz, G. (2021) · Medicina · doi:10.3390/medicina57050442 · Cited by 16 · see citing works

Hyperimmune immunoglobulin for people with COVID-19

Kimber, C., Valk, S. J., Chai, K. L., Piechotta, V., Iannizzi, C., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., McQuilten, Z., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015167.pub2 · Cited by 16 · see citing works

SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria

Marinov, G. K., Mladenov, M., Rangachev, A., & Alexiev, I. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274509 · Cited by 14 · see citing works

Recurrent and persistent infection with SARS-CoV-2 – epidemiological data and case reports from Western Sweden, 2020

Ringlander, J., Olausson, J., Nyström, K., Härnqvist, T., Jakobsson, H. E., & Lindh, M. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1957143 · Cited by 14 · see citing works

Wastewater-based modeling, reconstruction, and prediction for COVID-19 outbreaks in Hungary caused by highly immune evasive variants

Polcz, P., Tornai, K., Juhász, J., Cserey, G., Surján, G., Pándics, T., Róka, E., Vargha, M., Reguly, I. Z., Csikász‐Nagy, A., et al. (2023) · Water Research · doi:10.1016/j.watres.2023.120098 · Cited by 14 · see citing works

A Case Series Describing the Recurrence of COVID-19 in Patients Who Recovered from Initial Illness in Bangladesh

Das, P., Satter, S. M., Ross, A. G., Abdullah, Z., Nazneen, A., Sultana, R., Rimi, N. A., Chowdhury, K. I. A., Alam, M. R., Parveen, S., et al. (2021) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed6020041 · Cited by 13 · see citing works

Coronavirus new variants: the mutations cause and the effect on the treatment and vaccination

Raheem, R., Alsayed, R., Yousif, E. A., & Hairunisa, N. (2021) · Baghdad Journal of Biochemistry and Applied Biological Sciences · doi:10.47419/bjbabs.v2i02.54 · Cited by 13 · see citing works

Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study

Massonnaud, C., Roux, J., Colizza, V., & Crépey, P. (2022) · Vaccines · doi:10.3390/vaccines10030479 · Cited by 13 · see citing works

Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents

Patalon, T., Saciuk, Y., Hadad, H. O., Peretz, A., Peretz, A., Ben‐Tov, A., & Gazit, S. (2023) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2023.02.016 · Cited by 13 · see citing works

Clinical Features and Time to Recovery of Admitted COVID-19 Cases at Dilla University Referral Hospital Treatment Center, South Ethiopia

Churiso, G., Diriba, K., Girma, H., & Tafere, S. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s356606 · Cited by 12 · see citing works

Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals

Batchi-Bouyou, A. L., Djontu, J. C., Vouvoungui, J. C., Mapanguy, C. C. M., Ingoba, L. L., Mougany, J. S., Boumpoutou, R. K., Diafouka-Kietela, S., Ampa, R., & Ntoumi, F. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07593-y · Cited by 12 · see citing works

Mathematical modelling of the second wave of COVID-19 infections using deterministic and stochastic SIDR models

Lobato, F. S., Libotte, G. B., & Platt, G. M. (2021) · Nonlinear Dynamics · doi:10.1007/s11071-021-06680-0 · Cited by 12 · see citing works

Modelling how face masks and symptoms-based quarantine synergistically and cost-effectively reduce SARS-CoV-2 transmission in Bangladesh

Ferguson, E. A., Brum, E., Chowdhury, A., Chowdhury, S., Kundegorski, M. E., Mahmud, A. S., Purno, N. H., Sania, A., Steenson, R., Tasneem, M., et al. (2022) · Epidemics · doi:10.1016/j.epidem.2022.100592 · Cited by 12 · see citing works

COVID‐19 Reinfection in a Patient Receiving Immunosuppressive Treatment for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Gulati, K., Prendecki, M. F., Clarke, C., Willicombe, M. K., & McAdoo, S. P. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41671 · Cited by 11 · see citing works

Seasonal coronavirus protective immunity is short-lasting

Edridge, A. W. D., Kaczorowska, J., Hoste, A. C. R., Bakker, M., Klein, M., Loens, K., Jebbink, M. F., Matser, A., Kinsella, C. M., Rueda, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1083-1 · Cited by 767 · see citing works

Reinfection With SARS-CoV-2: Implications for Vaccines

Cohen, J. I., & Burbelo, P. D. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1866 · Cited by 109 · see citing works

Natural immune response and protection from SARS-CoV-2 reinfection

Margiotti, K., Fabiani, M., Mesoraca, A., & Giorlandino, C. (2021) · Acta Virologica · doi:10.4149/av_2021_401 · Cited by 2 · see citing works

Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020)

Kim, D. S., Rowland‐Jones, S., & Gea‐Mallorquí, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571481 · Cited by 49 · see citing works

Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection

Hanrath, A. T., Payne, B. A. I., & Duncan, C. J. A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.12.023 · Cited by 103 · see citing works